Literature DB >> 24469564

Chronic myeloid leukemia with hyperdiploidy: a case report with review of literature.

Sushma Belurkar1, Chethan Manohar, Annamma Kurien.   

Abstract

Chronic myeloid leukemia (CML) is a common marrow stem cell neoplasm characterized by the presence of the Philadelphia (Ph) chromosome in more than 90% of patients. Studies have shown that CML can be associated with various other cytogenetic abnormalities. 5-10% of these cases can show complex translocations involving other chromosomes in addition to Ph chromosome. Here, we report a Ph-positive CML patient with a hyperdiploid karyotype who presented clinically in chronic phase but progressed to blast crisis in spite of treatment with Imatinib. This case highlights the significance of cytogenetic abnormalities on the prognosis in CML.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24469564

Source DB:  PubMed          Journal:  Indian J Med Sci        ISSN: 0019-5359


  4 in total

1.  Philadelphia-positive case negative for JAK2 V617F mutation with hyperdiploidic karyotype: A case report.

Authors:  Dragomira Nikolova; Vera Damyanova; Vasil Hrischev; Maria Markova; Lubomir Mitev; Aselina Asenova; Atanas Radinov; Draga Toncheva
Journal:  Mol Clin Oncol       Date:  2019-10-04

2.  Chronic myeloid leukemia with variation of translocation at (Ph) [ins (22;9) (q11;q21q34)]: a case report.

Authors:  Zhiqiong Wang; Wen Zen; Fankai Meng; Xing Xin; Li Luo; Hanying Sun; Jianfeng Zhou; Lifang Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  Hyperdiploidy associated with T315I mutation in BCR-ABL kinase domain in an accelerated phase-chronic myeloid leukemia case.

Authors:  Walid Al-Achkar; Faten Moassass; Adnan Ikhtiar; Thomas Liehr; Moneeb Abdullah Kassem Othman; Abdulsamad Wafa
Journal:  Mol Cytogenet       Date:  2014-11-29       Impact factor: 2.009

4.  Masked inv dup(22)(q11.23), tetrasomy 8 and trisomy 19 in a blast crisis-chronic myeloid leukemia after interrupted Imatinib-treatment.

Authors:  Abdulsamad Wafa; Suher Almedani; Thomas Liehr; Walid Al-Achkar
Journal:  Mol Cytogenet       Date:  2015-12-23       Impact factor: 2.009

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.